FK866 can be a common NAMPT inhibitor with large efficacy. Comparative scientific tests of FK866 together with other compounds can offer a fresh look at for Discovering potential NAMPT inhibitors.Below we analyzed metabolic benefits conferred by PKM1 expression in this cancer context and found that PKM1 encourages NAD biosynthesis. These conclusion